Sino Biopharmaceutical reported CNY19.56B in Current Liabilities for its fiscal semester ending in December of 2024.


Current Liabilities Change Date
Alaunos Therapeutics USD 4K 822K Oct/2024
Avita Medical AUD 20.16M 6.37M Dec/2024
Cspc Pharmaceutical CNY 9.63B 801.28M Dec/2024
Dianthus Therapeutics USD 20.09M 1.64M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
IQVIA Holdings USD 7.57B 393M Jun/2025
Jiangsu Hengrui CNY 3.47B 102.17M Jun/2025
Moderna USD 1.57B 32M Jun/2025
Organon & Co USD 2.8B 181M Jun/2025
Revvity USD 671.81M 23.63M Jun/2025
Sino Biopharmaceutical CNY 19.56B 2.39B Dec/2024
Tectonic Therapeutic USD 11.36M 250K Jun/2025
Viatris USD 7.13B 1.41B Jun/2025
Xeris Pharmaceuticals USD 95.17M 5.27M Jun/2025